Samuel C. Blackman - Net Worth and Insider Trading
Samuel C. Blackman Net Worth
The estimated net worth of Samuel C. Blackman is at least $26 Million dollars as of 2024-12-26. Samuel C. Blackman is the HEAD OF R&D of Day One Biopharmaceuticals Inc and owns about 2,034,015 shares of Day One Biopharmaceuticals Inc (DAWN) stock worth over $26 Million. Details can be seen in Samuel C. Blackman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Samuel C. Blackman has not made any transactions after 2024-12-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Samuel C. Blackman
Samuel C. Blackman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Samuel C. Blackman owns 1 companies in total, including Day One Biopharmaceuticals Inc (DAWN) .
Click here to see the complete history of Samuel C. Blackman’s form 4 insider trades.
Insider Ownership Summary of Samuel C. Blackman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DAWN | Day One Biopharmaceuticals Inc | 2024-12-10 | Chief Medical Officer |
Samuel C. Blackman Latest Holdings Summary
Samuel C. Blackman currently owns a total of 1 stock. Samuel C. Blackman owns 2,034,015 shares of Day One Biopharmaceuticals Inc (DAWN) as of December 10, 2024, with a value of $26 Million.
Latest Holdings of Samuel C. Blackman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DAWN | Day One Biopharmaceuticals Inc | 2024-12-10 | 2,034,015 | 12.86 | 26,147,263 |
Holding Weightings of Samuel C. Blackman
Samuel C. Blackman Form 4 Trading Tracker
According to the SEC Form 4 filings, Samuel C. Blackman has made a total of 35 transactions in Day One Biopharmaceuticals Inc (DAWN) over the past 5 years, including 0 buys and 35 sells. The most-recent trade in Day One Biopharmaceuticals Inc is the sale of 30,000 shares on December 10, 2024, which brought Samuel C. Blackman around $399,300.
Insider Trading History of Samuel C. Blackman
- 1
Samuel C. Blackman Trading Performance
Samuel C. Blackman Ownership Network
Samuel C. Blackman Owned Company Details
What does Day One Biopharmaceuticals Inc do?
Who are the key executives at Day One Biopharmaceuticals Inc?
Samuel C. Blackman is the Chief Medical Officer of Day One Biopharmaceuticals Inc. Other key executives at Day One Biopharmaceuticals Inc include COO & CFO and Secretary York Charles N Ii , director & Chief Executive Officer Jeremy Bender , and 10 percent owner Ai Day 1 Llc .
Day One Biopharmaceuticals Inc (DAWN) Insider Trades Summary
Over the past 18 months, Samuel C. Blackman made 18 insider transaction in Day One Biopharmaceuticals Inc (DAWN) with a net sale of 240,340. Other recent insider transactions involving Day One Biopharmaceuticals Inc (DAWN) include a net sale of 122,037 shares made by Jeremy Bender , a net sale of 72,915 shares made by York Charles N Ii , and a net sale of 18,175 shares made by Adam Dubow .
In summary, during the past 3 months, insiders sold 88,527 shares of Day One Biopharmaceuticals Inc (DAWN) in total and bought 0 shares, with a net sale of 88,527 shares. During the past 18 months, 463,467 shares of Day One Biopharmaceuticals Inc (DAWN) were sold and 1,475,454 shares were bought by its insiders, resulting in a net purchase of 1,011,987 shares.
Day One Biopharmaceuticals Inc (DAWN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Day One Biopharmaceuticals Inc Insider Transactions
Samuel C. Blackman Mailing Address
Above is the net worth, insider trading, and ownership report for Samuel C. Blackman. You might contact Samuel C. Blackman via mailing address: 395 Oyster Point Blvd., Suite 217, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
